Arcturus Therapeutics Holdings
-$1.42 (-3.02%) Today
+$0.34 (+0.75%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.
About ARCT
Arcturus Therapeutics Holdings, Inc. is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF.
CEO
Joseph E. Payne
Employees
118
Headquarters
San Diego, California
Founded
2013
ARCT Key Statistics
Market Cap
1.20B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
419.12K
High Today
$47.51
Low Today
$45.25
Open Price
$47.51
Volume
280.25K
52 Week High
$129.71
52 Week Low
$24.87
Analyst Ratings
54%
of 13 ratings
Buy
53.8%
Hold
7.7%
Sell
38.5%
ARCT Earnings
-$2.15
-$1.43
-$0.72
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours